RFK Jr. Ignites Controversy by Challenging FDA’s Ban on Risky Peptides

Health Secretary Robert F. Kennedy Jr.'s push to deregulate unproven peptides signals a potential shift toward a more permissive, yet controversial, approach to drug safety standards. This move validates the growing biohacking subculture while raising alarms among medical experts about the risks of prioritizing anecdotal success over rigorous clinical data.